J Kevin Buchi Benitec Biopharma Inc. (BNTC) insider trading activity

BNTC Quotes by TradingView

J Kevin Buchi is Director of Benitec Biopharma Inc.. Currently has a direct ownership of 103,910 shares of BNTC, which is worth approximately $1.32 Million. The most recent transaction as insider was on Feb 27, 2025, when has been sold 51,813 shares (Common Stock) at a price of $3.86 per share, resulting in proceeds of $199,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 104K
99.45% 3M change
99.45% 12M change
Total Value Held $1.32 Million

J KEVIN BUCHI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 27 2025
BUY
Exercise of conversion of derivative security
$199,998 $3.86 p/Share
51,813 Added 33.27%
103,910 Common Stock
Aug 11 2023
BUY
Open market or private purchase
-
51,813 Added 49.86%
52,097 Common Stock

Also insider at

AMRX
Amneal Pharmaceuticals, Inc. Healthcare
Director
AMPE
Ampio Pharmaceuticals, Inc. Healthcare
Director
TCRT
Alaunos Therapeutics, Inc. Healthcare
Director
DRNA
Dicerna Pharmaceuticals Inc
Director
JKB

J Kevin Buchi

Director
Boston, MA

Track Institutional and Insider Activities on BNTC

Follow Benitec Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BNTC shares.

Notify only if

Insider Trading

Get notified when an Benitec Biopharma Inc. insider buys or sells BNTC shares.

Notify only if

News

Receive news related to Benitec Biopharma Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BNTC